2022
DOI: 10.1039/d1ra08136e
|View full text |Cite
|
Sign up to set email alerts
|

Development of novel bone targeting peptide–drug conjugate of 13-aminomethyl-15-thiomatrine for osteoporosis therapy

Abstract: 13-Aminomethyl-15-thiomatrine (M19) previously developed by our research group was a promising candidate for novel anti-osteoporosis drug development.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 39 publications
0
2
0
Order By: Relevance
“…Collagen gel containing HAP is selected to mimic the natural environment of bone for the progression of breast cancer cells. [ 17,18 ] The results showed that the liposome PTX‐Glu6 5 ‐Lip group could distinctly suppress the cytostatic activity of MDA‐MB‐231 cells, indicating the precedence of Glu6 5 functionalization for the treatment of bone metastasis compared with other groups (Figure 2d).…”
Section: Resultsmentioning
confidence: 98%
See 1 more Smart Citation
“…Collagen gel containing HAP is selected to mimic the natural environment of bone for the progression of breast cancer cells. [ 17,18 ] The results showed that the liposome PTX‐Glu6 5 ‐Lip group could distinctly suppress the cytostatic activity of MDA‐MB‐231 cells, indicating the precedence of Glu6 5 functionalization for the treatment of bone metastasis compared with other groups (Figure 2d).…”
Section: Resultsmentioning
confidence: 98%
“…Collagen gel containing HAP is selected to mimic the natural environment of bone for the progression of breast cancer cells. [17,18] The results…”
Section: Hap Binding Assaymentioning
confidence: 99%